Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
基本信息
- 批准号:10306953
- 负责人:
- 金额:$ 57.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:Active Biological TransportAcuteAddressAdrenergic AgentsAmino AcidsAnimal ModelAnimalsArteriesBiochemistryBlood PressureBlood VesselsBlood flowC-terminalCalcineurinCell NucleusCell physiologyCellsChemosensitizationChronicComplexCoupledCouplingCyclic AMP-Dependent Protein KinasesDataDevelopmentDiabetes MellitusDiffusionDiseaseElectrophysiology (science)Exposure toFosteringFoundationsGene ExpressionGlucoseGoalsHealthHumanIon ChannelKnowledgeLasersLateralMediatingMembraneMembrane ProteinsMicroscopyMissionModelingMolecularMusMuscle CellsMyographyNanoscopyNeuronsOpticsPathologyPhosphorylationPhosphorylation SitePhysiologicalPhysiologyPlayProcessProteinsPublic HealthRegulationRisk FactorsRoleSignal PathwaySignal TransductionSiteSmooth Muscle MyocytesSourceSurfaceTechniquesTestingTherapeuticUnited States National Institutes of HealthVesicleWorkbasediabetic patientexperimental studyextracellularhealth goalsin silicoinnovationnanonanoscalenon-diabeticnovelnovel therapeutic interventionparticlepatch clamppressureresponsetooltraffickingtranscription factor NF-AT c3treatment strategyvasoconstrictionvoltage
项目摘要
Abstract .
How a given protein organizes into a functional complex in health and disease is particularly relevant for
membrane proteins that serve as key information entry points for cells. A suitable and highly relevant example
is voltage-gated L-type CaV1.2 channels, which play a major role in arterial myocyte function and vascular
reactivity. These channels have been shown to gate in unison (i.e. cooperative gating) to amplify Ca2+ influx. At
present, however, a comprehensive understanding of mechanisms fostering the induction of CaV1.2 cooperative
gating as well as its functional implications in health and disease represent major knowledge gaps. The overall
objective of this proposal is to investigate the requirement and physiological consequences whereby
phosphorylation of a single amino acid – S1928 – in the C-terminal of vascular CaV1.2 channels promotes
dynamic spatial organization of CaV1.2 to facilitate cooperative gating at the surface membrane. To accomplish
this goal, we are testing the central hypothesis that CaV1.2 S1928 phosphorylation tunes dynamic channel
clustering and cooperative gating, and that this contributes to modulate vascular function in response to elevated
extracellular glucose and during diabetes. This hypothesis is formulated on the basis of strong and rigorous
preliminary data revealing an unanticipated and remarkable role for S1928 phosphorylation as the culprit for
redistribution and assembly of CaV1.2 subunits into superclusters at the surface membrane of arterial myocytes
upon elevated glucose and diabetes. CaV1.2 superclusters mediated by S1928 phosphorylation promotes
CaV1.2 cooperative gating and Ca2+ influx amplification into arterial myocytes. Key findings that further
underscore the significance of our observations is that CaV1.2 S1928 phosphorylation is necessary for
activation of prohypertensive signaling pathways, vasoconstriction and altered blood flow upon elevated glucose
and during diabetes. Moreover, critical observations have been validated in freshly dissociated human arterial
myocytes from nondiabetic and diabetic patients, underscoring the translational relevance. Emerging and
innovative concepts that will be explored in this application are the role of S1928 phosphorylation as 1) a
rheostat of CaV1.2 function and vascular reactivity and 2) a major risk factor for vascular complications in
diabetes. A multiscale contemporary approach that includes innovative microscopy techniques, sophisticated
biochemistry, electrophysiology, in silico analysis and unique animal models will be implemented to explore the
following aims. Aim 1 is to elucidate the role of S1928 phosphorylation in dynamic CaV1.2 clustering and
cooperative gating upon elevated glucose. Aim 2 is to examine the requirement of S1928 phosphorylation to
induce CaV1.2 superclustering and cooperative gating in arterial myocytes during diabetes. Results will transform
our understanding of how CaV1.2 are organized in arterial myocytes (and perhaps other cells) in health and
disease and may lay the foundation for novel therapeutic strategies with single amino acid accuracy to correct
channel function and vascular reactivity.
抽象的。
在健康和疾病中,给定的蛋白质如何组织成功能复合体尤其与
膜蛋白是细胞的关键信息入口点。一个合适且高度相关的例子
是电压门控的L型钙通道,在动脉肌细胞功能和血管中起主要作用
反应性。这些通道被证明是一致的(即协同门控)来放大钙离子的内流。在…
然而,目前对促进CaV1.2合作的诱导的机制有了全面的理解
门控及其在健康和疾病中的功能影响是主要的知识差距。整体而言
这项建议的目的是调查需求和生理后果,
血管CaV1.2通道C末端单一氨基酸S1928的磷酸化促进
CaV1.2的动态空间组织有助于表膜上的协作门控。要完成
为了达到这个目标,我们正在检验CaV1.2 S1928磷酸化调节动态通道的中心假设
聚集和协作门控,这有助于调节血管功能,以响应升高
细胞外葡萄糖和糖尿病期间。这一假设是在强有力和严谨的基础上提出的
初步数据显示S1928磷酸化作为疾病的罪魁祸首具有意想不到的显著作用
CaV1.2亚基在动脉肌细胞表面膜上的重新分布和组装成超簇
因为血糖升高和糖尿病。S1928磷酸化介导的CaV1.2超星团促进
CaV1.2协同门控和Ca~(2+)内流放大作用。主要发现进一步
强调我们观察到的重要性是CaV1.2 S1928磷酸化是必要的
高血糖时高血压信号通路的激活、血管收缩和血流改变
在糖尿病期间。此外,批判性的观察结果在新鲜分离的人类动脉中得到了验证。
来自非糖尿病和糖尿病患者的心肌细胞,强调了翻译的相关性。新兴市场和
将在本申请中探索的创新概念是S1928磷酸化作为1)a
CaV1.2功能和血管反应性的变阻器以及2)血管并发症的主要危险因素
糖尿病。一种多尺度的当代方法,包括创新的显微技术,复杂的
将应用生物化学、电生理学、电子分析和独特的动物模型来探索
遵循目标。目的1阐明S1928磷酸化在动态CaV1.2聚集和
合作控制血糖升高。目标2是研究S1928磷酸化对
诱导糖尿病大鼠动脉肌细胞CaV1.2超聚集和协同门控。结果将发生变化
我们对CaV1.2如何在健康和健康的动脉肌细胞(可能还有其他细胞)中组织的理解
并可能为新的治疗策略奠定基础,以单一氨基酸的准确性纠正
通道功能和血管反应性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manuel F Navedo其他文献
Manuel F Navedo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manuel F Navedo', 18)}}的其他基金
Regulation of a cardiac b1AR/SERCA2 complex in heart failure
心力衰竭中心脏 b1AR/SERCA2 复合物的调节
- 批准号:
10641923 - 财政年份:2022
- 资助金额:
$ 57.91万 - 项目类别:
Regulation of a cardiac b1AR/SERCA2 complex in heart failure
心力衰竭中心脏 b1AR/SERCA2 复合物的调节
- 批准号:
10539066 - 财政年份:2022
- 资助金额:
$ 57.91万 - 项目类别:
cAMP signaling in vascular smooth muscle in health and disease
健康和疾病状态下血管平滑肌中的 cAMP 信号传导
- 批准号:
10370716 - 财政年份:2021
- 资助金额:
$ 57.91万 - 项目类别:
cAMP signaling in vascular smooth muscle in health and disease
健康和疾病状态下血管平滑肌中的 cAMP 信号传导
- 批准号:
10532163 - 财政年份:2021
- 资助金额:
$ 57.91万 - 项目类别:
A single amino acid in CaV1.2 controls channel activity and arterial tone in hypertension
CaV1.2 中的单个氨基酸控制高血压中的通道活性和动脉张力
- 批准号:
10392387 - 财政年份:2019
- 资助金额:
$ 57.91万 - 项目类别:
Cerebral Vascular Smooth Muscle Dysfunction in Alzheimer's Disease
阿尔茨海默氏病的脑血管平滑肌功能障碍
- 批准号:
10488479 - 财政年份:2019
- 资助金额:
$ 57.91万 - 项目类别:
Coupling of Vascular Cav1.2 Channels In Health & Disease
健康中血管 Cav1.2 通道的耦合
- 批准号:
8960054 - 财政年份:2015
- 资助金额:
$ 57.91万 - 项目类别:
Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
- 批准号:
10613545 - 财政年份:2015
- 资助金额:
$ 57.91万 - 项目类别:
Coupling of vascular CaV1.2 channels in health and disease
血管 CaV1.2 通道在健康和疾病中的耦合
- 批准号:
10451644 - 财政年份:2015
- 资助金额:
$ 57.91万 - 项目类别:
Calcium sparklets-induced vascular dysfunction during diabetes
糖尿病期间钙火花诱导的血管功能障碍
- 批准号:
7982925 - 财政年份:2010
- 资助金额:
$ 57.91万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 57.91万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 57.91万 - 项目类别:
Operating Grants














{{item.name}}会员




